Literature DB >> 15229063

Which factors influence psychiatrists' selection of antidepressants?

Mark Zimmerman1, Michael Posternak, Michael Friedman, Naureen Attiullah, Scott Baymiller, Robert Boland, Stacie Berlowitz, Shahzad Rahman, Kirsten Uy, Steve Singer.   

Abstract

OBJECTIVE: There is little empirical evidence to guide clinicians in choosing among the diverse array of antidepressants available. In the absence of replicated empirical research guiding the selection of antidepressants, it is of interest to examine what factors psychiatrists consider when prescribing antidepressants.
METHOD: For 1,137 depressed patients who received a new antidepressant prescription, the treating psychiatrist completed a 43-item questionnaire listing factors that might have influenced the choice of antidepressant medication. The questionnaire was filled out immediately after an antidepressant was prescribed to treat a depressive disorder.
RESULTS: The most common factors influencing antidepressant selection were the avoidance of specific side effects, the presence of comorbid psychiatric disorders, and the presence of specific clinical symptoms. Prior treatment history, including prior positive or failed response to a drug, was the next most frequently endorsed factor influencing medication choice. Some factors that have been commonly discussed in the literature, such as concern about discontinuation syndrome and drug-drug interactions, rarely influenced antidepressant selection.
CONCLUSIONS: Because relatively little research has examined clinical features associated with differential response to the newer generation of antidepressants, a study of psychiatrists' prescribing practices highlights priorities for future controlled research. Our results suggest that two priority areas are the treatment of depression with coexisting anxiety symptoms/anxiety disorders and the influence of particular symptoms on response to different medications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229063     DOI: 10.1176/appi.ajp.161.7.1285

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  32 in total

Review 1.  How should primary care doctors select which antidepressants to administer?

Authors:  Gerald Gartlehner; Kylie Thaler; Seth Hill; Richard A Hansen
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Managing depression in primary care: achieving remission.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

3.  Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study.

Authors:  Kang Sim; N B Lee; Hong C Chua; Rathi Mahendran; Senta Fujii; Shu-Yu Yang; Mian-Yoon Chong; Tianmei Si; Yan L He; Min S Lee; Kil M Sung; Eun K Chung; Yiong H Chan; Naotaka Shinfuku; Chay H Tan; Norman Sartorius; Ross J Baldessarini
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

4.  Depression in the Primary Care Setting. Reply.

Authors:  Lawrence T Park; Carlos A Zarate
Journal:  N Engl J Med       Date:  2019-06-06       Impact factor: 91.245

5.  Taking the depressed "person" into account before moving into personalized or precision medicine.

Authors:  Koen Demyttenaere
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

6.  The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder.

Authors:  Michael Liebowitz; Harry A Croft; Daniel K Kajdasz; Heidi Whalen; Susan Gallipoli; Maria Athanasiou; Carol R Reed
Journal:  Psychopharmacol Bull       Date:  2011-09-15

7.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 8.  The role of dopaminergic agents in improving quality of life in major depressive disorder.

Authors:  Waguih William IsHak; Michael Davis; Jessica Jeffrey; Konstantin Balayan; Robert N Pechnick; Kara Bagot; Mark Hyman Rapaport
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 9.  Anxious depression: clinical features and treatment.

Authors:  Sanjai Rao; Sidney Zisook
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

10.  Treatment patterns in inpatient depression care.

Authors:  Alessa von Wolff; Ramona Meister; Martin Härter; Levente Kriston
Journal:  Int J Methods Psychiatr Res       Date:  2015-08-18       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.